Attachment A
Section 301 of the Federal Food, Drug, and Cosmetic Act
(21 U.S.C. 331)
Sec. 331. Prohibited acts
The following acts and the causing thereof are prohibited:
(a) The introduction or delivery for introduction into interstate
commerce of any food, drug, device, or cosmetic that is adulterated or
misbranded.
(b) The adulteration or misbranding of any food, drug, device, or
cosmetic in interstate commerce.
(c) The receipt in interstate commerce of any food, drug, device, or
cosmetic that is adulterated or misbranded, and the delivery or
proffered delivery thereof for pay or otherwise.
(d) The introduction or delivery for introduction into interstate
commerce of any article in violation of section 344, 355, or 360bbb-3 of
this title.
(e) The refusal to permit access to or copying of any record as
required by section 350a, 350c, 354, 360bbb-3, 373, or 374(a) of this
title; or the failure to establish or maintain any record, or make any
report, required under section 350a, 350c(b), 354, 355(i) or (k),
360b(a)(4)(C), 360b(j), (l) or (m), 360ccc-1(i).,\1\ 360e(f), 360i, or
360bbb-3 of this title, or the refusal to permit access to or
verification or copying of any such required record.
---------------------------------------------------------------------------
\1\ So in original.
---------------------------------------------------------------------------
(f) The refusal to permit entry or inspection as authorized by
section 374 of this title.
(g) The manufacture within any Territory of any food, drug, device,
or cosmetic that is adulterated or misbranded.
(h) The giving of a guaranty or undertaking referred to in section
333(c)(2) of this title, which guaranty or undertaking is false, except
by a person who relied upon a guaranty or undertaking to the same effect
signed by, and containing the name and address of, the person residing
in the United States from whom he received in good faith the food, drug,
device, or cosmetic; or the giving of a guaranty or undertaking referred
to in section 333(c)(3) of this title, which guaranty or undertaking is
false.
(i)(1) Forging, counterfeiting, simulating, or falsely representing,
or without proper authority using any mark, stamp, tag, label, or other
identification device authorized or required by regulations promulgated
under the provisions of section 344 or 379e of this title.
(2) Making, selling, disposing of, or keeping in possession,
control, or custody, or concealing any punch, die, plate, stone, or
other thing designed to print, imprint, or reproduce the trademark,
trade name, or other identifying mark, imprint, or device of another or
any likeness of any of the foregoing upon any drug or container or
labeling thereof so as to render such drug a counterfeit drug.
(3) The doing of any act which causes a drug to be a counterfeit
drug, or the sale or dispensing, or the holding for sale or dispensing,
of a counterfeit drug.
(j) The using by any person to his own advantage, or revealing,
other than to the Secretary or officers or employees of the Department,
or to the courts when relevant in any judicial proceeding under this
chapter, any information acquired under authority of section 344, 348,
350a, 350c, 355, 360, 360b, 360c, 360d, 360e, 360f, 360h, 360i, 360j,
360ccc, 360ccc-1, 360ccc-2.,\1\ 374, 379, or 379e of this title
concerning any method or process which as a trade secret is entitled to
protection; or the violating of section 346a(i)(2) of this title or any
regulation issued under that section..\1\ This paragraph does not
authorize the withholding of information from either House of Congress
or from, to the extent of matter within its jurisdiction, any committee
or subcommittee of such committee or any joint committee of Congress or
any subcommittee of such joint committee.
(k) The alteration, mutilation, destruction, obliteration, or
removal of the whole or any part of the labeling of, or the doing of any
other act with respect to, a food, drug, device, or cosmetic, if such
act is done while such article is held for sale (whether or not the
first sale) after shipment in interstate commerce and results in such
article being adulterated or misbranded.
(l) Repealed. Pub. L. 105-115, title IV, Sec. 421, Nov. 21, 1997,
111 Stat. 2380.
(m) The sale or offering for sale of colored oleomargarine or
colored margarine, or the possession or serving of colored oleomargarine
or colored margarine in violation of subsections (b) or (c) of section
347 of this title.
(n) The using, in labeling, advertising or other sales promotion of
any reference to any report or analysis furnished in compliance with
section 374 of this title.
(o) In the case of a prescription drug distributed or offered for
sale in interstate commerce, the failure of the manufacturer, packer, or
distributor thereof to maintain for transmittal, or to transmit, to any
practitioner licensed by applicable State law to administer such drug
who makes written request for information as to such drug, true and
correct copies of all printed matter which is required to be included in
any package in which that drug is distributed or sold, or such other
printed matter as is approved by the Secretary. Nothing in this
paragraph shall be construed to exempt any person from any labeling
requirement imposed by or under other provisions of this chapter.
(p) The failure to register in accordance with section 360 of this
title, the failure to provide any information required by section 360(j)
or 360(k) of this title, or the failure to provide a notice required by
section 360(j)(2) of this title.
(q)(1) The failure or refusal to (A) comply with any requirement
prescribed under section 360h or 360j(g) of this title, (B) furnish any
notification or other material or information required by or under
section 360i or 360j(g) of this title, or (C) comply with a requirement
under section 360l of this title.
(2) With respect to any device, the submission of any report that is
required by or under this chapter that is false or misleading in any
material respect.
(r) The movement of a device in violation of an order under section
334(g) of this title or the removal or alteration of any mark or label
required by the order to identify the device as detained.
(s) The failure to provide the notice required by section 350a(c) or
350a(e) of this title, the failure to make the reports required by
section 350a(f)(1)(B) of this title, the failure to retain the records
required by section 350a(b)(4) of this title, or the failure to meet the
requirements prescribed under section 350a(f)(3) of this title.
(t) The importation of a drug in violation of section 381(d)(1) of
this title, the sale, purchase, or trade of a drug or drug sample or the
offer to sell, purchase, or trade a drug or drug sample in violation of
section 353(c) of this title, the sale, purchase, or trade of a coupon,
the offer to sell, purchase, or trade such a coupon, or the
counterfeiting of such a coupon in violation of section 353(c)(2) of
this title, the distribution of a drug sample in violation of section
353(d) of this title or the failure to otherwise comply with the
requirements of section 353(d) of this title, or the distribution of
drugs in violation of section 353(e) of this title or the failure to
otherwise comply with the requirements of section 353(e) of this title.
(u) The failure to comply with any requirements of the provisions
of, or any regulations or orders of the Secretary, under section
360b(a)(4)(A), 360b(a)(4)(D), or 360b(a)(5) of this title.
(v) The introduction or delivery for introduction into interstate
commerce of a dietary supplement that is unsafe under section 350b of
this title.
(w) The making of a knowingly false statement in any statement,
certificate of analysis, record, or report required or requested under
section 381(d)(3) of this title; the failure to submit a certificate of
analysis as required under such section; the failure to maintain records
or to submit records or reports as required by such section; the release
into interstate commerce of any article or portion thereof imported into
the United States under such section or any finished product made from
such article or portion, except for export in accordance with section
381(e) or 382 of this title, or with section 262(h) of title 42; or the
failure to so export or to destroy such an article or portions thereof,
or such a finished product.
(x) The falsification of a declaration of conformity submitted under
section 360d(c) of this title or the failure or refusal to provide data
or information requested by the Secretary under paragraph (3) of such
section.
(y) In the case of a drug, device, or food--
(1) the submission of a report or recommendation by a person
accredited under section 360m of this title that is false or
misleading in any material respect;
(2) the disclosure by a person accredited under section 360m of
this title of confidential commercial information or any trade
secret without the express written consent of the person who
submitted such information or secret to such person; or
(3) the receipt by a person accredited under section 360m of
this title of a bribe in any form or the doing of any corrupt act by
such person associated with a responsibility delegated to such
person under this chapter.
(z) The dissemination of information in violation of section 360aaa
of this title.
(aa) The importation of a prescription drug in violation of section
384 of this title, the falsification of any record required to be
maintained or provided to the Secretary under such section, or any other
violation of regulations under such section.
(bb) The transfer of an article of food in violation of an order
under section 334(h) of this title, or the removal or alteration of any
mark or label required by the order to identify the article as detained.
(cc) The importing or offering for import into the United States of
an article of food by, with the assistance of, or at the direction of, a
person debarred under section 335a(b)(3) of this title.
(dd) The failure to register in accordance with section 350d of this
title.
(ee) The importing or offering for import into the United States of
an article of food in violation of the requirements under section 381(m)
of this title.
(ff) The importing or offering for import into the United States of
a drug or device with respect to which there is a failure to comply with
a request of the Secretary to submit to the Secretary a statement under
section 381(o) of this title.
(gg) The knowing failure to comply with paragraph (7)(E) of section
374(g) of this title; the knowing inclusion by a person accredited under
paragraph (2) of such section of false information in an inspection
report under paragraph (7)(A) of such section; or the knowing failure of
such a person to include material facts in such a report.
File Type | application/msword |
File Title | Attachment A |
Author | ATaylor |
Last Modified By | Jonna Capezzuto |
File Modified | 2007-03-12 |
File Created | 2007-03-12 |